Aptevo Therapeutics Inc. (APVO) stock
APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-3.25%)
Close on Nov 18, 2026Market cap $803.68KP/E –Yield –
Aptevo Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aptevo Therapeutics's market cap was $1.08M on Nov 11, 2026, against $19.05M a year earlier. Over the last 5 years it ranged from $772.87K to $33.90B, with a median of $40.36M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.08M | -85.1% |
| 2025 | Dec 31, 2025 | $7.23M | -81.8% |
| 2024 | Dec 31, 2024 | $39.72M | -98.3% |
| 2023 | Dec 29, 2023 | $2.30B | -77.8% |
| 2022 | Dec 30, 2022 | $10.39B | -69.3% |
| 2021 | Dec 31, 2021 | $33.90B | -67.5% |
| 2020 | Dec 31, 2020 | $104.23B | +399.8% |
| 2019 | Dec 31, 2019 | $20.86B | +2.9% |
| 2018 | Dec 31, 2018 | $20.27B | -68.3% |
| 2017 | Dec 29, 2017 | $63.92B | +83.9% |
| 2016 | Dec 30, 2016 | $34.76B | – |
See a number that looks wrong?